Related Experiment Video
Updated: Jan 27, 2026

Phosphoproteomic Strategy for Profiling Osmotic Stress Signaling in Arabidopsis
Published on: June 25, 2020
Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets
Francesca Sacco1, Anett Seelig2, Sean J Humphrey3
1Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, 82152 Martinsried, Germany; Department of Biology, University of Rome Tor Vergata, 00100 Rome, Italy.
Abstract:
Progressive decline of pancreatic beta cell function is central to the pathogenesis of type 2 diabetes. Protein phosphorylation regulates glucose-stimulated insulin secretion from beta cells, but how signaling networks are remodeled in diabetic islets in vivo remains unknown. Using high-sensitivity mass spectrometry-based proteomics, we quantified 6,500 proteins and 13,000 phosphopeptides in islets of obese diabetic mice and matched controls, revealing drastic remodeling of key kinase hubs and signaling pathways. Integration with a literature-derived signaling network implicated GSK3 kinase in the control of the beta cell-specific transcription factor PDX1. Deep phosphoproteomic analysis of human islets chronically treated with high glucose demonstrated a conserved glucotoxicity-dependent role of GSK3 kinase in regulating insulin secretion. Remarkably, the ability of beta cells to secrete insulin in response to glucose was rescued almost completely by pharmacological inhibition of GSK3. Thus, our resource enables investigation of mechanisms and drug targets in type 2 diabetes.
Insights
Type 2 diabetes involves declining pancreatic beta cell function. Inhibiting GSK3 kinase in beta cells restored insulin secretion, offering a potential new drug target for diabetes.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Diseases
Background:
- Pancreatic beta cell dysfunction is key in type 2 diabetes pathogenesis.
- Protein phosphorylation is crucial for insulin secretion, but its network changes in diabetic islets are unclear.
Purpose of the Study:
- To investigate changes in protein phosphorylation signaling networks in diabetic islets.
- To identify potential therapeutic targets for type 2 diabetes.
Main Methods:
- High-sensitivity mass spectrometry-based proteomics and phosphoproteomics were used on islets from obese diabetic mice and human islets.
- Quantitative analysis of over 6,500 proteins and 13,000 phosphopeptides.
- Integration with signaling networks and pharmacological inhibition of identified kinases.
Main Results:
- Significant remodeling of kinase hubs and signaling pathways was observed in diabetic islets.
- GSK3 kinase was implicated in regulating the beta cell transcription factor PDX1.
- GSK3 inhibition in human islets restored glucose-stimulated insulin secretion, counteracting glucotoxicity.
Conclusions:
- GSK3 kinase plays a conserved, glucotoxicity-dependent role in regulating beta cell insulin secretion.
- Pharmacological inhibition of GSK3 shows promise for rescuing beta cell function in type 2 diabetes.
- This study provides a valuable resource for understanding diabetes mechanisms and identifying drug targets.
Related Concept Videos
Hypothalamic-Pituitary Axis
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

